Febuxostat api Febuxostat intermediate cas 144060-53-7

Febuxostat is an orally available, non-purine inhibitor of xanthine oxidase with uric acid lowering activity.

Febuxostat is a new generation xanthine oxidase inhibitor developed by Tejin Co. (Japan,) used clinically for for long-term treatment of hyperuicemia (gout,) a new and highly effective non-purine selective inhibitor of xanthine oxidase. It is not recommended for gout patients without hyperuricemia.

febuxostat is used in the treatment of:

·Long-standing high uric acid levels in the blood

High levels of uric acid in the blood lead to development of crystals which deposit in the joints, causing pain, swelling and tenderness, known as a condition called gout.

ADENURIC contains the active ingredient febuxostat.

It works by reducing the formation and accumulation of uric acid in the blood to reduce crystal formation. ADENURIC is used to prevent gout, but is not used to treat acute attacks of gout.

Adenuric Active Ingredient Febuxostat 99%

Gout Treatment Powder in Stock

Gout Dosing Uloric Pharmaceutical Raw Material

Chemical Name: Febuxostat

Febuxostat (Uloric)

FBX

Uloric

Febuxostat (TEI-6720)

Febuxostat Tablets

FEBUXOSTAT API

Febuxostat (This product is unavailable in the U.S.)

Febuxostat Tabletshehe

Febuxostat Impurity

Febuxostat, >=99%

Febuxostat IMP

FEBUXOSTAT

Tei-6720

Molecular Formula: C16H16N2O3S

Formula Weight: 316.37

CAS No.: 144060-53-7

Contact us if you need more details on Adenuric Active Ingredient Febuxostat 99%. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Gout Treatment Powder in Stock、Gout Dosing Uloric Pharmaceutical Raw Material. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Top Products Apixaban Lurasidone